Hemab Therapeutics is building a differentiated coagulation franchise targeting underserved rare bleeding disorders. Learn ...
GENEVA, Switzerland - The first clinical trial is underway of an antiviral drug's effectiveness in people exposed to the ...
The first clinical trial of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the ...
MedPage Today on MSN
Aspirin Alone Gets the Job Done for Clot Prevention After Joint Surgery
Regimens may drop the direct anticoagulants for some patients, based on EPCAT III ...
GlobalData on MSN
Novo Nordisk reports Phase III FRONTIER4 study results for denecimig
The interim analysis included 426 participants aged one year and above.
PEP, aims to assess the effectiveness of the antiviral obeldesivir in post-exposure prophylaxis, for people who have been in ...
The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent ...
The Manila Times on MSN
Trial of potential Ebola antiviral under way — WHO
GENEVA, Switzerland — The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the ...
A recent study published in Indian Pediatric in June 2025 reveals that while routine stress ulcer prophylaxis isn't ...
Epidemic continues to spread at unprecedented pace, into new areas, while efforts to control remain insufficient, says ...
Gedatolisib is the first approved agent to inhibit class I PI3K isoforms plus both mTOR complexes, addressing a long-standing challenge in comprehensive PI3K/AKT/mTOR pathway blockade. The indication ...
Geneva: The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the deadly Ebola ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results